These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27039398)

  • 21. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
    Lin Y; Chen H; Hu Z; Mao Y; Xu X; Zhu Y; Xu X; Wu J; Li S; Mao Q; Zheng X; Xie L
    FEBS Lett; 2013 Aug; 587(15):2467-73. PubMed ID: 23796420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noncoding RNAs Regulating Cancer Signaling Network.
    Hu J; Markowitz GJ; Wang X
    Adv Exp Med Biol; 2016; 927():297-315. PubMed ID: 27376740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma.
    Jia LF; Wei SB; Gan YH; Guo Y; Gong K; Mitchelson K; Cheng J; Yu GY
    Int J Cancer; 2014 Nov; 135(10):2282-93. PubMed ID: 24343426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.
    Lu YF; Zhang L; Waye MM; Fu WM; Zhang JF
    Exp Cell Res; 2015 May; 334(1):173-82. PubMed ID: 25857406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-214 as a key hub that controls cancer networks: small player, multiple functions.
    Penna E; Orso F; Taverna D
    J Invest Dermatol; 2015 Apr; 135(4):960-969. PubMed ID: 25501033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-34a: a potential therapeutic target in human cancer.
    Li XJ; Ren ZJ; Tang JH
    Cell Death Dis; 2014 Jul; 5(7):e1327. PubMed ID: 25032850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncoding RNAs in Tumor Angiogenesis.
    Khorshidi A; Dhaliwal P; Yang BB
    Adv Exp Med Biol; 2016; 927():217-41. PubMed ID: 27376737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
    Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
    Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
    Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression and regulation of microRNA-125b in cancers.
    Huang K; Dong S; Li W; Xie Z
    Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):803-5. PubMed ID: 23800395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-139-5p: promising biomarker for cancer.
    Zhang HD; Jiang LH; Sun DW; Li J; Tang JH
    Tumour Biol; 2015 Mar; 36(3):1355-65. PubMed ID: 25691250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.
    Sha H; Gan Y; Xu F; Zhu Y; Zou R; Peng W; Wu Z; Ma R; Wu J; Feng J
    J Cell Mol Med; 2022 Feb; 26(4):977-989. PubMed ID: 35014178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-124: An emerging therapeutic target in cancer.
    Jia X; Wang X; Guo X; Ji J; Lou G; Zhao J; Zhou W; Guo M; Zhang M; Li C; Tai S; Yu S
    Cancer Med; 2019 Sep; 8(12):5638-5650. PubMed ID: 31389160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique MicroRNA signature and clinical outcome of cancers.
    Yu SL; Chen HY; Yang PC; Chen JJ
    DNA Cell Biol; 2007 May; 26(5):283-92. PubMed ID: 17504024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
    Zheng M; Sun X; Li Y; Zuo W
    Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-197: A novel biomarker for cancers.
    Wang DD; Chen X; Yu DD; Yang SJ; Shen HY; Sha HH; Zhong SL; Zhao JH; Tang JH
    Gene; 2016 Oct; 591(2):313-9. PubMed ID: 27320730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple functions of hypoxia-regulated miR-210 in cancer.
    Qin Q; Furong W; Baosheng L
    J Exp Clin Cancer Res; 2014 Jun; 33(1):50. PubMed ID: 24909053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel serum microRNA-based identification and classification biomarker of human glioma.
    Xing W; Zeng C
    Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.